Boule Diagnostics AB has won a tender for 136 Medonic systems in partnership with one of its Indian distributors. The tender was in Uttar Pradesh, the most densely populated state in India with around 200 million inhabitants. The instruments will be installed in 136 hospitals starting in early July 2016.
“Our strategic targeting of India – where we have had a sales office since late 2013 – has proved correct. In the first quarter of this year, we have doubled our sales compared to previous year and have now won this important tender,” said Ernst Westman, Group President and CEO, Boule Diagnostics AB.
For more information, please contact:
Ernst Westman, President and CEO, Boule Diagnostics AB, phone +46 708-60 88 63
About Boule Diagnostics AB
Boule Diagnostics AB is a fast-growing diagnostics company, developing and manufacturing systems and consumables for hematology diagnostics for the public healthcare providers worldwide. The company is primarily focused on small and medium-sized hospitals, clinics and laboratories in outpatient care as well as other diagnostics companies in both human and veterinary hematology. The group is comprised of operating subsidiaries in Sweden, the US and China. The Boule Diagnostics share is traded on NASDAQ Nordic since 2011. http://www.boule.se
The information in this press release is such that Boule Diagnostics AB must disclose it in accordance with the Securities Market Act and/or the Financial Instruments Trading. The information was submitted for publication in Swedish at 8:30 am (CET), May 10, 2016.